Lunai Bioworks Inc.
US ˙ NasdaqCM ˙ US29350E1047
ESTE SÍMBOLO NÃO ESTÁ MAIS ATIVO

SecurityRENB / Lunai Bioworks Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership497,011 shares
Latest Disclosed Value $ 438,364
Vanguard Group Inc reports 3.98% decrease in ownership of RENB / Lunai Bioworks Inc.

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 497,011 shares of Lunai Bioworks Inc. (US:RENB) valued at $438,364 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 517,625 shares of Lunai Bioworks Inc.. This represents a change in shares of -3.98% during the quarter. The current value of the position is $705,756 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F LUNAI BIOWORKS COM SHS 29350E203 497,011 -20,614 -3.98 438 -40.41 0.0000
2025-11-07 2025-09-30 13F RENOVARO COM 29350E104 0 -100.00 0
2025-11-07 2025-09-30 13F LUNAI BIOWORKS COM SHS 29350E203 517,625 517,625 735 0.0000
2025-08-11 2025-06-30 13F RENOVARO COM 29350E104 4,924,629 -735,704 -13.00 1,423 -53.69 0.0000
2025-05-09 2025-03-31 13F RENOVARO COM 29350E104 5,660,333 -58,461 -1.02 3,074 -35.71 0.0001
2025-02-11 2024-12-31 13F RENOVARO COM 29350E104 5,718,794 -809 -0.01 4,781 73.06 0.0001
2024-11-13 2024-09-30 13F RENOVARO COM 29350E104 5,719,603 75,576 1.34 2,763 -72.04 0.0000
2024-08-13 2024-06-30 13F RENOVARO COM 29350E104 5,644,027 1,727,355 44.10 9,877 -4.84 0.0002
2024-05-10 2024-03-31 13F RENOVARO COM 29350E104 3,916,672 3,526,565 904.00 10,379 739.72 0.0002
2024-03-11 2023-12-31 13F/A-1 RENOVARO BIOSCIENCES COM 29350E104 390,107 118,782 43.78 1,237 1.98 0.0000
2024-02-14 2023-12-31 13F RENOVARO BIOSCIENCES COM 29350E104 390,107 118,782 1,237 0.0000
2023-12-18 2023-09-30 13F/A-1 RENOVARO BIOSCIENCES COM 29350E104 271,325 44,296 19.51 1,213 846.88 0.0000
2023-11-14 2023-09-30 13F RENOVARO BIOSCIENCES COM 29350E104 271,325 44,296 1,213 0.0000
2023-08-14 2023-06-30 13F ENOCHIAN BIOSCIENCES COM 29350E104 227,029 -95,247 -29.55 129 -56.46 0.0000
2023-07-14 2023-03-31 13F/A-1 ENOCHIAN BIOSCIENCES COM 29350E104 322,276 -436,427 -57.52 295 -62.36 0.0000
2023-05-15 2023-03-31 13F ENOCHIAN BIOSCIENCES COM 29350E104 322,276 -436,427 295 0.0000
2023-02-10 2022-12-31 13F ENOCHIAN BIOSCIENCES COM 29350E104 758,703 3,540 0.47 781 -42.87 0.0000
2022-11-14 2022-09-30 13F ENOCHIAN BIOSCIENCES COM 29350E104 755,163 17,526 2.38 1,367 -3.94 0.0000
2022-08-12 2022-06-30 13F ENOCHIAN BIOSCIENCES COM 29350E104 737,637 -198,637 -21.22 1,423 -81.58 0.0000
2022-05-13 2022-03-31 13F ENOCHIAN BIOSCIENCES COM 29350E104 936,274 -2,096 -0.22 7,725 12.92 0.0002
2022-02-14 2021-12-31 13F ENOCHIAN BIOSCIENCES COM 29350E104 938,370 681,314 265.04 6,841 295.43 0.0002
2021-11-12 2021-09-30 13F ENOCHIAN BIOSCIENCES COM 29350E104 257,056 -16,600 -6.07 1,730 27.11 0.0000
2021-08-13 2021-06-30 13F ENOCHIAN BIOSCIENCES COM 29350E104 273,656 -52,662 -16.14 1,361 17.84 0.0000
2021-05-14 2021-03-31 13F ENOCHIAN BIOSCIENCES COM 29350E104 326,318 8,285 2.61 1,155 23.13 0.0000
2021-02-12 2020-12-31 13F ENOCHIAN BIOSCIENCES COM 29350E104 318,033 6,236 2.00 938 -16.03 0.0000
2020-11-16 2020-09-30 13F ENOCHIAN BIOSCIENCES COM 29350E104 311,797 -359,483 -53.55 1,117 -60.47 0.0000
2020-08-14 2020-06-30 13F ENOCHIAN BIOSCIENCES COM 29350E104 671,280 -6,270 -0.93 2,826 39.07 0.0001
2020-05-15 2020-03-31 13F ENOCHIAN BIOSCIENCES COM 29350E104 677,550 896 0.13 2,032 -40.18 0.0001
2020-02-14 2019-12-31 13F ENOCHIAN BIOSCIENCES COM 29350E104 676,654 162,581 31.63 3,397 20.16 0.0001
2019-11-14 2019-09-30 13F ENOCHIAN BIOSCIENCES COM 29350E104 514,073 -21,534 -4.02 2,827 17.25 0.0001
2019-08-14 2019-06-30 13F ENOCHIAN BIOSCIENCES COM 29350E104 535,607 27,039 5.32 2,411 -31.70 0.0001
2019-05-15 2019-03-31 13F ENOCHIAN BIOSCIENCES COM 29350E104 508,568 508,568 3,530 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.